TR201909969T4 - 4-[5-(Piridin-4-il)-lh-l,2,4-Triazol-3-il]Piridin-2- Karbonitrilin Kristalin Formu. - Google Patents

4-[5-(Piridin-4-il)-lh-l,2,4-Triazol-3-il]Piridin-2- Karbonitrilin Kristalin Formu. Download PDF

Info

Publication number
TR201909969T4
TR201909969T4 TR2019/09969T TR201909969T TR201909969T4 TR 201909969 T4 TR201909969 T4 TR 201909969T4 TR 2019/09969 T TR2019/09969 T TR 2019/09969T TR 201909969 T TR201909969 T TR 201909969T TR 201909969 T4 TR201909969 T4 TR 201909969T4
Authority
TR
Turkey
Prior art keywords
carbonitrile
triazol
pyridin
pyridine
crystalline form
Prior art date
Application number
TR2019/09969T
Other languages
English (en)
Inventor
Iwabuchi Yoshiyuki
Miyata Sachiho
Sato Takahiro
Uda Junichiro
Kandou Takamitsu
Inoue Tadashi
Nakano Hiroyuki
Original Assignee
Fuji Yakuhin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49997324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201909969(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fuji Yakuhin Co Ltd filed Critical Fuji Yakuhin Co Ltd
Publication of TR201909969T4 publication Critical patent/TR201909969T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Buluş, 4-[5-(piridin-4-il)-1H-1,2,4-triazol-3-il]piridin-2-karbonitril?in kristalli bir polimorfu ve bunun için bir üretim yöntemi ile ilgilidir.
TR2019/09969T 2012-07-25 2013-07-24 4-[5-(Piridin-4-il)-lh-l,2,4-Triazol-3-il]Piridin-2- Karbonitrilin Kristalin Formu. TR201909969T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012177539 2012-07-25

Publications (1)

Publication Number Publication Date
TR201909969T4 true TR201909969T4 (tr) 2019-07-22

Family

ID=49997324

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/09969T TR201909969T4 (tr) 2012-07-25 2013-07-24 4-[5-(Piridin-4-il)-lh-l,2,4-Triazol-3-il]Piridin-2- Karbonitrilin Kristalin Formu.

Country Status (17)

Country Link
US (1) US9199970B2 (tr)
EP (1) EP2878598B1 (tr)
JP (1) JP6158811B2 (tr)
KR (1) KR20150035585A (tr)
CN (1) CN104411700B (tr)
AU (1) AU2013293973B2 (tr)
CA (1) CA2876391C (tr)
DK (1) DK2878598T3 (tr)
ES (1) ES2732360T3 (tr)
HU (1) HUE045138T2 (tr)
IL (1) IL236130B (tr)
NZ (1) NZ703638A (tr)
RU (1) RU2639149C2 (tr)
TR (1) TR201909969T4 (tr)
TW (1) TWI598346B (tr)
WO (1) WO2014017515A1 (tr)
ZA (1) ZA201500468B (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105315260A (zh) * 2014-07-29 2016-02-10 北京海步医药科技股份有限公司 一种托布司他一水合物晶型及其制备方法
WO2016134854A1 (en) 2015-02-25 2016-09-01 Pharmathen S.A. Methods for the preparation of topiroxostat and intermediates thereof
CN105693699B (zh) * 2015-03-30 2019-06-18 苏州晶云药物科技股份有限公司 托吡司他的晶型及其制备方法
CN106279111A (zh) * 2015-05-12 2017-01-04 北京济美堂医药研究有限公司 一种精制托吡司他的新方法
CN104961730B (zh) * 2015-06-18 2017-05-17 山东金城医药化工股份有限公司 托吡司他新晶型及其制备方法
CN105130958B (zh) * 2015-08-31 2017-10-31 济南康和医药科技有限公司 5‑(2‑氰基4‑吡啶基)‑3‑(4‑吡啶基)‑1,2,4‑三唑的制备工艺
CN107759570B (zh) * 2016-08-18 2019-09-03 山东诚创医药技术开发有限公司 一种托普司他对甲苯磺酸盐的精制方法
CN108250183A (zh) * 2016-12-29 2018-07-06 北京诚济制药有限公司 一种高纯度的托匹司他的制备方法
JP2020516488A (ja) 2017-04-12 2020-06-11 ヒューレット−パッカード デベロップメント カンパニー エル．ピー．Ｈｅｗｌｅｔｔ‐Ｐａｃｋａｒｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏｍｐａｎｙ， Ｌ．Ｐ． 印刷サブアセンブリ
CN107089971A (zh) * 2017-05-10 2017-08-25 山东新华制药股份有限公司 高纯度托匹司他的制备方法
CN107474040A (zh) * 2017-08-21 2017-12-15 赵剑锋 一种5‑（2‑氰基‑4‑吡啶基）‑3‑（4‑吡啶基）‑1,2,4‑三唑的精制方法
CN109620756B (zh) * 2018-12-10 2021-12-17 广州市晶硅新材料有限公司 一种化妆品用有机硅复合粉末及其制备方法
CN110613692A (zh) * 2019-09-17 2019-12-27 杭州百诚医药科技股份有限公司 一种托匹司他片剂及其制备方法
CN114685452A (zh) * 2020-12-31 2022-07-01 鲁南制药集团股份有限公司 一种托匹司他-水杨酸-乙酸三元共晶
US12447604B2 (en) * 2021-11-01 2025-10-21 Grant Kenji Larsen Robotic assistance device using reduction of cognitive load of a user
CN116421573B (zh) * 2023-05-06 2024-02-23 湖南一格制药有限公司 托吡司特缓释制剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070021929A1 (en) 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computing methods for control of high-throughput experimental processing, digital analysis, and re-arraying comparative samples in computer-designed arrays
US20070020662A1 (en) 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computerized control of high-throughput experimental processing and digital analysis of comparative samples for a compound of interest
US20050095696A9 (en) 2000-01-07 2005-05-05 Lemmo Anthony V. Apparatus and method for high-throughput preparation and characterization of compositions
US20050118637A9 (en) 2000-01-07 2005-06-02 Levinson Douglas A. Method and system for planning, performing, and assessing high-throughput screening of multicomponent chemical compositions and solid forms of compounds
US20050089923A9 (en) 2000-01-07 2005-04-28 Levinson Douglas A. Method and system for planning, performing, and assessing high-throughput screening of multicomponent chemical compositions and solid forms of compounds
US7108970B2 (en) 2000-01-07 2006-09-19 Transform Pharmaceuticals, Inc. Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state
US20040252299A9 (en) 2000-01-07 2004-12-16 Lemmo Anthony V. Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions
EP1248869A2 (en) 2000-01-07 2002-10-16 Transform Pharmaceuticals, Inc. High-throughput formation, identification, and analysis of diverse solid-forms
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs
WO2003023409A2 (en) 2001-09-07 2003-03-20 Transform Pharmaceuticals, Inc. Apparatus and method for high-throughput preparation and characterization of compositions
CA2462132C (en) * 2002-01-28 2010-08-10 Fuji Yakuhin Co., Ltd. 1,2,4-triazole compounds
CN1826335A (zh) * 2003-07-24 2006-08-30 株式会社富士药品 1,2,4－三唑化合物的制造方法以及其中间体
JP2005041802A (ja) * 2003-07-25 2005-02-17 Fujiyakuhin Co Ltd １，２，４−トリアゾール化合物の製造方法
US20060189811A1 (en) 2004-07-23 2006-08-24 Fujiyakuhin Co., Ltd. Process for producing 1,2,4-triazole compound and intermediate therefor

Also Published As

Publication number Publication date
US9199970B2 (en) 2015-12-01
EP2878598A1 (en) 2015-06-03
CA2876391A1 (en) 2014-01-30
RU2015106137A (ru) 2016-09-20
AU2013293973B2 (en) 2017-04-06
NZ703638A (en) 2017-02-24
HK1205101A1 (en) 2015-12-11
ES2732360T3 (es) 2019-11-22
KR20150035585A (ko) 2015-04-06
RU2639149C2 (ru) 2017-12-20
EP2878598A4 (en) 2016-04-06
AU2013293973A1 (en) 2015-01-29
CN104411700B (zh) 2016-06-15
TWI598346B (zh) 2017-09-11
WO2014017515A1 (ja) 2014-01-30
CA2876391C (en) 2016-10-18
DK2878598T3 (da) 2019-08-12
JP6158811B2 (ja) 2017-07-05
JPWO2014017515A1 (ja) 2016-07-11
EP2878598B1 (en) 2019-06-19
IL236130B (en) 2019-08-29
IL236130A0 (en) 2015-02-01
ZA201500468B (en) 2016-10-26
TW201408659A (zh) 2014-03-01
HUE045138T2 (hu) 2019-12-30
US20150126558A1 (en) 2015-05-07
CN104411700A (zh) 2015-03-11

Similar Documents

Publication Publication Date Title
TR201909969T4 (tr) 4-[5-(Piridin-4-il)-lh-l,2,4-Triazol-3-il]Piridin-2- Karbonitrilin Kristalin Formu.
ZA201500462B (en) Method for producing 4-[5-(pyridin-4-yl)-1h-1,2,4-triazol-3-yl]pyridine-2-carbonitrile, and intermediate thereof
CY1119974T1 (el) Στερεες μορφες 3-(5-αμινο-2-μεθυλ-4-οξο-4η-κιναζολιν-3-υλ)-πιπεριδινο-2,6-διονης και φαρμακευτικες συνθεσεις και χρησεις αυτης
ME03556B (me) 3-[4-(7h-pirolo[2,3-d]pirimidin-4-il)-1 h-pirazol-1-il]oktan- ili нертan - niтril kао јак inhibiтori
DOP2013000072A (es) ((r)-(e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol cristalino.
UA116206C2 (uk) Спосіб боротьби з кліщами varroa destructor у бджіл
DK2657233T3 (da) 3,5-disubstitueret alkynylbenzenforbindelse og salt deraf
EP2635284A4 (en) Heterocyclic compounds and their use
EP2575462A4 (en) Heterocyclic compounds and their use
EA201400938A1 (ru) Способ получения 2-(2,3-диметилфенил)-1-пропаналя с использованием хлорацетона
EP2678420A4 (en) AUTOTROPHE HYDROGEN BACTERIA AND USES THEREOF
PT2912030T (pt) Processo melhorado de fabrico de 5-(2,6-di-4-morfolinil-4- pirimidinil)-4-trifluorometilpiridin-2-amina
SMT201500166B (it) Derivato di 1,2,4-triazolone
EP2935228A4 (en) TRIAZOLON COMPOUNDS AND USES THEREOF
CY1121096T1 (el) Οξικος 4-{4-[(ιε)-4-(2,9-διαζασπειρο[5.5]ενδεκ-2-υλο)βουτ-1-εν-1-υλο]-2-μεθυλοβενζυλο}-5-(προπαν-2-υλο)-1η-πυραζολ-3-υλο bhta-d-γλυκοπυρανοζιτης
ITMI20130577A1 (it) Metodo di scanalatura, utensile di scanalatura e struttura di supporto di utensile di scanalatura
CY1117545T1 (el) Πολυμορφα υδροχλωρικης 6-(πιπεριδιν-4-υλοξυ)-2η-ισοκινολιν-1-ονης
EP2776030A4 (en) 2,5-DISUBSTITUTED PYRIDYL NICOTINE LIGANDS AND USE THEREOF
ITBZ20110046A1 (it) Trinciatrice di materiale legnoso.
TH1501000274A (th) วิธีการผลิต 4-[5-(ไพริดิน-4-อิล)-1h-1,2,4-ไตรอะโซล-3-อิล]ไพริดีน-2-คาร์โบไนไตรล์ และสารมัธยันตร์ของสารดังกล่าว
UA88738U (uk) 5-(гептилтіо)-3-(феноксиметил)-1н-1,2,4-тріазол, що виявляє антигіпоксичну активність
UA88008U (en) 3-(phenoxymethyl)-5-(propylthio)-1h-1,2,4-triazole exhibiting actoprotector activity
TR201104910A2 (tr) Termal su yosunu üretim yönteminde yenilik.
TR200808077A2 (tr) Keçiboynuzu çayı ve bunun üretim yöntemi
TH132151A (th) ((r)-(e)-2-(4-(2-(5-(1-(3,5-ไดคลอโรไพริดิน-4-อิล)เอทธอกซี)-1h-อินดาซอล-3-อิล)ไวนิล)-1h-ไพราซอล-1-อิล)เอทธานอลเชิงผลึก